George Sands, Nisha Bansal and Wolfgang C. Winkelmayer/LinkedIn
Jun 5, 2026, 18:32
George Sands: A Thoughtful Editorial on Low-Dose Rivaroxaban in Advanced CKD
George Sands, Ex-Senior Medical Director of Pfizer, Principal of Sands Collaborative, shared a post on LinkedIn about a recent article by Nisha Bansal and Wolfgang C. Winkelmayer, published in JAMA, adding:
“Sharing a very thoughtful editorial by Bansal and Winkelmyer about a trial in CKD patients, stage 4 and 5.
This randomized study is very helpful. This patient population is very challenging to randomize in clinical trials.
This was a placebo-controlled trial vs low-dose rivaroxaban.
The editorial sums it all up beautifully; approximately 5-minute read.”
Title: Rivaroxaban for Cardiovascular Disease Prevention in Chronic Kidney Disease
Authors: Nisha Bansal, Wolfgang C. Winkelmayer
Stay updated on all sceintific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause